Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,100
Closed -$119K 4461
2025
Q3
$119K Sell
8,100
-700
-8% -$7.13K ﹤0.01% 3642
2025
Q2
$86.4K Buy
+8,800
New +$72.9K ﹤0.01% 3652
2023
Q4
Sell
-2,000
Closed -$30.9K 5177
2023
Q3
$30.9K Hold
2,000
﹤0.01% 4311
2023
Q2
$37.9K Buy
+2,000
New +$35.1K ﹤0.01% 4012
2023
Q1
Sell
-1,900
Closed -$24.2K 4969
2022
Q4
$24.2K Buy
+1,900
New +$17.1K ﹤0.01% 4342

Other funds holding ETNB

Walleye Trading's ETNB Position: Q4 2025 in Review

Walleye Trading sold out of 89bio (ETNB) in Q4 2025, closing a stake of 8,816 shares — an estimated $130K sold.

Walleye Trading first reported a position in ETNB in Q3 2022 and held it in 8 quarters. The position peaked at $789K in Q4 2022. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Walleye Trading reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Walleye Trading sold 8,816 89bio shares in Q4 2025, an estimated $130K.
  • Walleye Trading first reported a position in 89bio in Q3 2022 and held it in 8 quarters.
  • Walleye Trading's 89bio position peaked at $789K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Walleye Trading's 13F filing for Q4 2025, filed 13 Feb 2026.